Toxikon Corporation is an ISO 17025-accredited global Contract Research Organization that conducts safety studies for the medical device and biopharmaceutical industries, as well as academic research centers.
With more than 30 years of industry expertise, Toxikon provides testing services to meet FDA/ISO/ICH, OECD, USP and Japan's MHLW standards. Services include a complete range of PK, TK, ADME and toxicology studies and carcinogenicity, bioavailability, chemical characterization, impurities analysis and synthesis, bioanalytical and microbiology assays.
Toxikon operates a 125,000 square-foot facility at their headquarters in Bedford, Massachusetts and has additional offices in the U.S., Europe and Asia. Toxikon also maintains a subsidiary in Belgium to facilitate growing demands from international clients.